Universal Health Services' Q3 earnings fall 8.3% despite revenue growth, as rising costs and Acute Care pricing pressure offset higher patient volumes.
Why CON Stock advanced +1.63% Today — RQD Quant Desk Flash
Concentra Group Holdings Parent Inc. (CON) carries a Roarable Rating of C (Hold) with 64/100 RQD Confidence. The underlying business is intact, so current owners don’t need to panic-sell—but mixed big-money flow or rich pricing means new buyers can afford to wait for either a pullback or a B-or-higher upgrade.
Why CON Stock advanced +1.63% Today — RQD Quant Desk Flash
Concentra Group Holdings Parent Inc. (CON) advanced +1.63% to $41.25 as options desks priced 55% call premium vs. 45% put protection around the $40 max-pain magnet. Solid 41% profit margin (20% return on capital), mixed timing at 32x P/E—hold if owned, no rush to chase.
- ▸Technical Tape: Trading at 99% of its 52-week range ($18.55 – $41.52) with RSI-14 at 65.8 (BULLISH MOMENTUM).
- ▸Whale Options Positioning: $2.5M in bullish call flow vs. $2.0M in put flow (Put/Call 0.82x, implied earnings swing ±6.9%).
- ▸Fundamental Anchor: Roarable C (Hold) backed by 44% gross margin and $197.1M annual free cash flow.
Here is how Concentra Group (CON) and Centene (CNC) have performed compared to their sector so far this year.
Centene's Q3 earnings beat estimates as Medicare revenues surge 19.9% despite falling membership, while management lifts its 2026 adjusted profit outlook.
Concentra Group Holdings Parent recently opened new occupational health centers in Arlington, Virginia and Pensacola, Florida, extending its network to employers in two employment heavy corridors with services spanning w
PENSACOLA, Fla., October 22, 2026--Concentra®, the nation’s leader in occupational medicine, today announced the opening of its first medical center in Pensacola, expanding its presence to the Florida Panhandle and provi
Elevance Health (ELV) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Elevance Health beats Q3 EPS estimate by 50% as Carelon grows despite declining medical membership, and lifts its 2026 underlying earnings baseline to $26.75.
Stephens & Co. initiates coverage on Concentra Group Holdings (NYSE:CON) with a Overweight rating and announces Price Target of $45.
Today's Top 3 RQD Strong Buys & Whale Accumulation Setups (Live CON Tape Review)
- ✓Live breakdown of today’s highest-scoring RQD Green-Light breakouts
- ✓1 urgent Red-Light accounting trap to cut from your watchlist immediately
- ✓Bring any ticker to live Q&A—we run it through the 5-Pillar RQD Radar on screen
CON Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. +13.9% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on CON today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for CON. Explore sector supply chains on /butterfly.
CON Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDWhy is CON stock moving today?
Why CON Stock advanced +1.63% Today — RQD Quant Desk Flash. Solid 41% profit margin (20% return on capital), mixed timing at 32x P/E—hold if owned, no rush to chase.